tiprankstipranks
Trending News
More News >
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market

InMed Pharmaceuticals (INM) Income Statement

Compare
385 Followers

InMed Pharmaceuticals Income Statement

Last quarter (Q1 2026), InMed Pharmaceuticals's total revenue was C$1.12M, a decrease of -11.43% from the same quarter last year. In Q1, InMed Pharmaceuticals's net income was C$-1.73M. See InMed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 4.94MC$ 4.60MC$ 4.14MC$ 1.09MC$ 0.00
Gross Profit
C$ 1.71MC$ 1.10MC$ 1.40MC$ 543.55KC$ 0.00
Operating Expenses
C$ 9.62MC$ 9.24MC$ 9.78MC$ 14.34MC$ 12.17M
Depreciation and Amortization
C$ 534.73KC$ 604.52KC$ 596.00KC$ 511.79KC$ 149.84K
EBITDA
C$ -7.26MC$ -7.06MC$ -7.78MC$ -13.28MC$ -12.17M
Operating Income
C$ -7.92MC$ -8.13MC$ -8.38MC$ -13.79MC$ -12.17M
Other Income/Expenses
C$ -244.14KC$ 465.98KC$ 444.26KC$ -4.81MC$ -478.14K
Pretax Income
C$ -8.16MC$ -7.67MC$ -7.93MC$ -18.60MC$ -12.65M
Net Income
C$ -8.16MC$ -7.68MC$ -7.95MC$ -18.60MC$ -12.65M
Per Share Metrics
Basic EPS
C$ -11.44C$ -27.55C$ -86.00C$ -21.35KC$ -938.91
Diluted EPS
C$ -11.44C$ -27.55C$ -86.00C$ -21.35KC$ -938.91
Weighted Average Shares Outstanding
975.99K 381.05K 122.42K 1.12K 13.44K
Weighted Average Shares Outstanding (Diluted)
975.99K 381.05K 122.42K 1.12K 13.44K
Currency in CAD

InMed Pharmaceuticals Earnings and Revenue History